Showing 7 posts of 7 posts found.


Hundreds of patients turn to private cannabis clinics in UK

August 16, 2019
Medical Communications Marijuana, NHS, UK, cannabis, medicinal cannabis, pharma

Hundreds of people have turned to private clinics, in an effort to gain access to medicinal cannabis in the UK, …


UK Government call for more research into medicinal cannabis

July 4, 2019
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CBMP, Marijuana, UK, medicinal cannabis, pharma, politics

The British government has called for more research into cannabis-based medicinal products (CBMPs). In a paper published on 3 July, …

Fewer opioids prescribed in states with medical marijuana, research shows

June 12, 2019
Research and Development Marijuana, medicinal cannabis, opioids, pharma

Fewer opioids are prescribed in states with legal medical marijuana, according to research from University of Texas Medical Branch at …

Novartis inks deal with Canadian cannabis firm Tilray

December 18, 2018
Research and Development Marijuana, Novartis, Sandoz, Tilray, cannabis

Shares in Canadian cannabis company Tilray jumped by more than 11% today after the British Columbia-based firm announced its entry …


CBD dampens activity in brain regions associated with psychosis, study shows

August 30, 2018
Research and Development CBD, King's College London, Kings College London, Marijuana, psychosis, study

Cannabidiol (CBD), one of the major constituents of cannabis, may be beneficial for patients with psychotic disorders due to its …


Top Ten most popular articles on this week

March 23, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma

As me move startlingly quickly towards Easter, it’s time for another Top Ten rundown. This week, Celgene surprised the industry …


GW Pharma releases positive data on cannabidiol-based Phase III trial

September 28, 2016
Research and Development Epidiolex, GW Pharmaceuticals, Marijuana, Medical marijuana, cannabis

GW Pharmaceuticals’ Epidiolex is designed to treat seizures in a rare form of epilepsy called Lennox-Gaustaut Syndrome. GW pharmaceuticals published …

Latest content